Efficacy and safety of novel GZ667161 glucosylceramide synthase inhibitor to modulate CNS glucocerebrosidase activity and synucleinopathies in pre-clinical and clinical studies investigating Parkinson’s disease: a systematic review
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI